×
0 0 0 0.0275962236746551 0.0275962236746551 0.151466957153232 0.192084241103849 0.173674655047204
Stockreport

Could Cara Therapeutics, Inc. Be a Millionaire-Maker Stock? [The Motley Fool]

CARA THERAPEUTICS (CARA)  More Company Research Source: The Motley Fool
Last cara therapeutics earnings: 5/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.caratherapeutics.com/investor-relations
PDF Could Cara be the answer for investors itching to make $1 million? You've probably heard the expression no pain, no gain. In Cara Therapeutics ' ( NASDAQ:CARA ) case, it's more like no pain, big gain. The biotech's lead candidate, CR845, is in a late-stage study for relief of post-operative pain. CR845 is also in another late-stage study for treatment of chronic kidney disease-associated pruritus (CKD-aP), a chronic itching experienced by many patients on dialysis. Good news from those studies should send Cara stock through the roof. But could Cara Therapeutics really be a millionaire-maker stock? Let's take a look. Image source: Getty Images. The opportunities Several months ago, I wrote about two possibilities for where Cara Therapeutics could be in five years . In the dream scenario, the biotech would report stellar results from its phase 3 post-operative pain study in the first half of this year. That would lead to a regulatory filing for the intraveno [Read more]

IMPACT SNAPSHOT EVENT TIME: CARA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS